Live Rate
| Open | |
|---|---|
| High | |
| Low | |
| Prev. Close | |
| Lower circuit | |
| Upper circuit | |
| 52w High | |
| 52w Low | |
| P/E Ratio |
Gujarat Kidney & Super Speciality Listing Price
| Exchange | Listing Price | Gain/Loss | % |
|---|---|---|---|
| NSE | ₹120.00 | +₹6.00 | +5.26% |
| BSE | ₹120.75 | +₹6.75 | +5.92% |
Gujarat Kidney & Super Speciality Subscription
Last updated on 24-Dec-2025 18:19:02
| Category | Offered | Applied | Times |
|---|---|---|---|
| QIBs | 7726880 | 8188928 | 1.06 |
| HNIs | 3300000 | 18899840 | 5.73 |
| HNIs 10+ | 2200000 | 11552896 | 5.25 |
| HNIs 2+ | 1100000 | 7346944 | 6.68 |
| Retail | 2200000 | 41880320 | 19.04 |
| Total | 13226880 | 68969088 | 5.21 |
Application-Wise Breakup (Approx. no. of Apps) | |||
|---|---|---|---|
| Category | Reserved | Applied | Times |
| HNIs (10L+) | 1228 | 1275 | 1.04 |
| HNIs (2-10L) | 614 | 3680 | 5.99 |
| Retail | 17188 | 254876 | 14.83 |
| Total Applications: 259831 | |||
| © IPO Premium | |||
| Subscription Demand (in ₹ crore) | |||
|---|---|---|---|
| Category | Offered | Demand | Times |
| QIBs | 88.09 | 93.35 | 1.06 |
| FIIs | - | 49.36 | - |
| DIIs | - | 0 | - |
| Mutual funds | - | 0.05 | - |
| Others | - | 43.94 | - |
| HNIs | 37.62 | 215.46 | 5.73 |
| HNIs 10+ | 25.08 | 131.7 | 5.25 |
| HNIs 2+ | 12.54 | 83.76 | 6.68 |
| Retail | 25.08 | 477.44 | 19.04 |
| Total | 150.79 | 786.25 | 5.21 |
| QIB Interest Cost per share (7 Days) | |||||
|---|---|---|---|---|---|
| @7% ₹0.2 | @8% ₹0.2 | @9% ₹0.2 | @10% ₹0.2 | @11% ₹0.3 | @12% ₹0.3 |
Gujarat Kidney & Super Speciality Lot(s) Distribution
| Category | Lot(s) | Qty | Amount | Reserved |
|---|---|---|---|---|
| Retail | 1 | 128 | 14592 | 17188 |
| sHNI | 14 | 1792 | 204288 | 614 |
| bHNI | 69 | 8832 | 1006848 | 1228 |
Gujarat Kidney & Super Speciality Reservation
| Category | Shares Offered | % |
|---|---|---|
| Anchor | 8773120 | 39.88% |
| QIB | 7726880 | 35.12% |
| HNI | 3300000 | 15% |
| Retail | 2200000 | 10% |
| Total | 22000000 | 100% |
Gujarat Kidney & Super Speciality About
IPO Details
| Total Issue Size | 2,20,00,000 shares (aggregating up to ₹250.8 Cr) |
| Fresh Issue Size | 2,20,00,000 shares (aggregating up to ₹250.8 Cr) |
| Face Value | ₹2/- Per Share |
| Issue Type | Bookbuilding IPO |
| Listing At | BSE , NSE |
| Share Holding Pre Issue | 5,68,43,250 Shares |
| Share Holding Post Issue | 7,88,43,250 shares |
Key Performance Indicators (KPI)
| KPI | Jun-25 | Mar-25 | Mar-24 | Mar-23 |
|---|---|---|---|---|
| ROE | 15.85% | 36.61% | 15.86% | -1.67% |
| ROCE | 18.91% | 37.65% | 9.79% | -1.70% |
| Debt/ Equity | 0.13 | 0.15 | 0.18 | 0 |
| P/E Pre IPo | 61.22 | |||
| P/E Post IPO | 41.59 |
Company Financial (In ₹Crore)
| Period Ended | Jun-25 | Mar-25 | Mar-24 | Mar-23 |
|---|---|---|---|---|
| Assets | 61.59 | 55.34 | 20.53 | 3.87 |
| Total Income | 15.27 | 40.4 | 5.48 | 0 |
| Profit After Tax | 5.4 | 9.5 | 1.71 | -0.01 |
| EBITDA | 8.63 | 16.55 | 1.95 | -0.01 |
| NET Worth | 30.56 | 25.71 | 10.8 | 0.37 |
| Reserves and Surplus | 19.42 | 14.57 | 10.6 | 0.17 |
| Total Borrowing | 4.03 | 3.88 | 1.94 | 0 |
Peer Comparision (Valuation)
| Company | P/E (x) | CMP*(₹) | Face value (₹) |
|---|---|---|---|
| Yatharth Hospital & Trauma Care Services Limited | 55.84 | 822 | 10 |
| Gpt Healthcare Limited | 24.51 | 149 | 10 |
| Kmc Speciality Hospitals (india) Ltd | 52.6 | 69.00 | 1 |
| Gujarat Kidney & Super Speciality Limited | 61.22 | - | 2 |
Peer Comparision (Financial Performance)
| Company | NAV/Share (₹) | RoNW (%) | EPS (Basic) (₹) |
|---|---|---|---|
| Yatharth Hospital & Trauma Care Services Limited | 166.62 | 8.13 | 14.72 |
| Gpt Healthcare Limited | 30.21 | 20.14 | 6.08 |
| Kmc Speciality Hospitals (india) Ltd | 10.08 | 13.04 | 1.31 |
| Gujarat Kidney & Super Speciality Limited | 5.04 | 36.61 | 1.85 |
About Company
Incorporation Year: 2019
Industry: Multispeciality healthcare services
Incorporated in 2019, Gujarat Kidney and Super Speciality Limited (GKASSL) is a Gujarat-based healthcare provider offering secondary and tertiary care services through a network of multispeciality hospitals.
The company operates seven hospitals and four pharmacies across Gujarat, with an overall bed infrastructure comprising a total capacity of 490 beds, an approved capacity of 455 beds, and an operational capacity of 340 beds.
GKASSL’s hospital network includes Gujarat Kidney and Superspeciality Hospital (Vadodara), Gujarat Multispeciality Hospital (Godhra), Raj Palmland Hospital Private Limited (Bharuch), M/s. Surya Hospital and ICU (Borsad), Gujarat Surgical Hospital (Vadodara), and Ashwini Medical Centre (Anand). In addition, the company runs Ashwini Medical Store in Anand.
The company provides general medical and surgical treatments under secondary care and advanced super speciality surgical procedures under tertiary care. Gujarat Superspeciality Hospital offers a wide range of services, including internal medicine, general and minimally invasive surgery, orthopaedics and trauma care, joint replacement, obstetrics and gynaecology, respiratory care, non-interventional cardiology, diabetology, and anaesthesiology.
Strength
Strong Expertise in Renal Sciences: The company has established capabilities in renal sciences with advanced sub-specialities, supported by multispeciality hospitals offering tertiary healthcare services.
Asset-Light Hospital Operating Model: Hospitals are operated through leased and majority-owned entities, enabling expansion without heavy investment in land, buildings, or major medical infrastructure.
Ability to Attract and Retain Skilled Medical Talent: Low attrition levels among doctors and nurses reflect the company’s success in attracting and retaining experienced healthcare professionals through a multidisciplinary, high-volume care model.
Weakness
Risk Related to Proposed Acquisition of Parekhs Hospital: The company plans to use issue proceeds to acquire 100% of Parekhs Hospital Private Limited. Any difficulty in completing the acquisition within agreed terms may adversely affect future plans and operations.
Funding Risk for Ashwini Medical Centre Acquisition: A portion of the issue proceeds is proposed to be used for part-payment of the already acquired Ashwini Medical Centre. Any delay in raising funds may impact timely payment to the sellers.
Execution and Approval Risks in New Hospital Expansion: The proposed setting up of a women’s healthcare hospital in Vadodara is subject to risks such as delays in approvals, procurement of capital equipment, cost escalation, and lease-related challenges, which may affect expansion plans and financial performance.
Gujarat Kidney & Super Speciality Latest Announcements
| Date | Subject | Attachment Text |
|---|
Gujarat Kidney & Super Speciality Financial Results
Gujarat Kidney & Super Speciality Lead Manager(s)
Gujarat Kidney & Super Speciality Address
Plot No. 1, City Sarve No. 1537/A,
Jetalpur Road, Gokak Mill Compound,
Alkapuri, Vadodara , Gujarat, India
Vadodara, Gujarat, 390020
Phone: +91 265 298 48
Email: info@gujaratsuperspecialityhospital.com
Website: http://www.gujaratsuperspecialityhospital.com/
Gujarat Kidney & Super Speciality Registrar
MUFG Intime India Private Limited (Link Intime)
Link Intime India Private Ltd
C 101, 247 Park,
L.B.S.Marg Vikhroli (West),
Mumbai - 400083